A Study of FolateScan in Patients With Knee Osteoarthritis

CompletedOBSERVATIONAL
Enrollment

25

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

October 31, 2011

Study Completion Date

October 31, 2012

Conditions
Knee Osteoarthritis
Interventions
DRUG

99mTc-EC20

Study participants underwent a one-time evaluation by FolateScan which entailed a single intravenous injection of 99mTc-EC20 (total volume of 1.0 to 2.0 ml administered over a period of 30 seconds with radioactive dose between 20 and 25 mCi). A total of three imaging scans were acquired: an early phase (at \~1 minute) SPECT/CT of both knees; a late phase (at \~60 minutes) SPECT/CT image of both knees; and a late phase (at \~80 minutes) planar image of the whole body was performed (anterior-posterior, and postero-anterior).

Trial Locations (1)

27710

Duke University Medical Center, Durham

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

collaborator

Endocyte

INDUSTRY

lead

Virginia Kraus

OTHER